Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Ligand Pharmaceuticals
Business Segments
Business Segments
Total revenues and income
Total revenues and income
Ligand Pharmaceuticals
·
Business Segments
·
1 segment
·
Rolls up to
Total Revenue
Breakdown
Segments
Business Segments
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Business Segments
$45.33M
$47.63M
$115.46M
$59.67M
$51.72M
$63.69M
Total
$45.33M
$47.63M
$115.46M
$59.67M
$51.72M
$63.69M